Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.01 | uM | 7 | 625.00 | 270.29 | 795.00 | 821.75 | 0.9675 | 0.9592 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 625.00 | 270.29 | 624.00 | 821.75 | 0.7594 | 0.6846 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 625.00 | 270.29 | 774.00 | 821.75 | 0.9419 | 0.9267 |
| BT-20 | Lapatinib | 10 | uM | 7 | 625.00 | 270.29 | 257.00 | 821.75 | 0.3128 | -0.0309 |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 625.00 | 270.29 | 843.00 | 821.75 | 1.0259 | 1.0321 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 625.00 | 270.29 | 790.00 | 821.75 | 0.9614 | 0.9515 |
| BT-20 | Lapatinib | 1 | uM | 7 | 625.00 | 270.29 | 729.00 | 821.75 | 0.8871 | 0.8561 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 625.00 | 270.29 | 812.00 | 821.75 | 0.9881 | 0.9852 |
| BT-20 | Erlotinib | 10 | uM | 7 | 625.00 | 270.29 | 531.00 | 821.75 | 0.6462 | 0.5234 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 625.00 | 270.29 | 490.00 | 821.75 | 0.5963 | 0.4490 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 625.00 | 270.29 | 893.00 | 821.75 | 1.0867 | 1.1064 |
| BT-20 | 17-AAG | 10 | uM | 7 | 625.00 | 270.29 | 278.00 | 821.75 | 0.3383 | 0.0177 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 625.00 | 270.29 | 715.00 | 821.75 | 0.8701 | 0.8338 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 888.00 | 821.75 | 1.0806 | 1.0990 | |
| BT-20 | Linsitinib | 10 | uM | 7 | 625.00 | 270.29 | 481.00 | 821.75 | 0.5853 | 0.4323 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 625.00 | 270.29 | 450.00 | 821.75 | 0.5476 | 0.3741 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 625.00 | 270.29 | 766.00 | 821.75 | 0.9322 | 0.9143 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 625.00 | 270.29 | 782.00 | 821.75 | 0.9516 | 0.9391 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 858.00 | 821.75 | 1.0441 | 1.0545 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 811.00 | 821.75 | 0.9869 | 0.9837 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 2.00 | 821.75 | 0.0024 | -0.9530 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 3.00 | 821.75 | 0.0037 | -0.9395 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 626.00 | 821.75 | 0.7618 | 0.6880 | |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 625.00 | 270.29 | 312.00 | 821.75 | 0.3797 | 0.0936 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 625.00 | 270.29 | 213.00 | 821.75 | 0.2592 | -0.1380 |